Nozomu Ogura, Shun Yamamoto, Ryuichi Morita, Hiroshi Imazeki, Hideaki Takahashi, Yoshitaka Honma, Daisuke Kurita, Koshiro Ishiyama, Hiroyuki Daiko, Yasuyuki Seto, Ken Kato. "Comparison between nivolumab plus ipilimumab, FOLFOX and nivolumab plus FOLFOX therapy as first-line treatment for cisplatin-unfit advanced esophageal squamous cell carcinoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.388